These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10499811)

  • 1. The architectural transition of human complement component C9 to poly(C9).
    DiScipio RG; Berlin C
    Mol Immunol; 1999 Jun; 36(9):575-85. PubMed ID: 10499811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of human complement C8 to C9: role of the N-terminal modules in the C8 alpha subunit.
    Scibek JJ; Plumb ME; Sodetz JM
    Biochemistry; 2002 Dec; 41(49):14546-51. PubMed ID: 12463754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic crossreactivity of the alpha subunit of complement component C8 with the cysteine-rich domain shared by complement component C9 and low density lipoprotein receptor.
    Tschopp J; Mollnes TE
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4223-7. PubMed ID: 2424021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of complement poly-C9 determined in projection by cryo-electron microscopy and single particle analysis.
    Biesecker G; Lachmann P; Henderson R
    Mol Immunol; 1993 Oct; 30(15):1369-82. PubMed ID: 8232323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The architecture of complement component C9 and poly(C9).
    DiScipio RG; Hugli TE
    J Biol Chem; 1985 Nov; 260(27):14802-9. PubMed ID: 4055801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between the C8 alpha-gamma and C8 beta subunits of human complement C8: role of the C8 beta N-terminal thrombospondin type 1 module and membrane attack complex/perforin domain.
    Musingarimi P; Plumb ME; Sodetz JM
    Biochemistry; 2002 Sep; 41(37):11255-60. PubMed ID: 12220191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Several epitopes on native human complement C9 are involved in interaction with the C5b-8 complex and other C9 molecules.
    Kontermann R; Deppisch R; Rauterberg EW
    Eur J Immunol; 1990 Mar; 20(3):623-8. PubMed ID: 1690659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the poly-C9 component of the complement membrane attack complex.
    Dudkina NV; Spicer BA; Reboul CF; Conroy PJ; Lukoyanova N; Elmlund H; Law RH; Ekkel SM; Kondos SC; Goode RJ; Ramm G; Whisstock JC; Saibil HR; Dunstone MA
    Nat Commun; 2016 Feb; 7():10588. PubMed ID: 26841934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of channels formed by poly C9, C5b-8 and the membrane attack complex of complement.
    Zalman LS; Müller-Eberhard HJ
    Mol Immunol; 1990 Jun; 27(6):533-7. PubMed ID: 1696352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between polymerization of complement component C9 and membrane channel formation.
    DiScipio RG
    J Immunol; 1991 Dec; 147(12):4239-47. PubMed ID: 1721643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of refolding conformers of complement protein C9 during insertion into membranes.
    Laine RO; Esser AF
    Nature; 1989 Sep; 341(6237):63-5. PubMed ID: 2475785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric and truncated forms of human complement protein C8 alpha reveal binding sites for C8 beta and C8 gamma within the membrane attack complex/perforin region.
    Plumb ME; Scibek JJ; Barber TD; Dunlap RJ; Platteborze PL; Sodetz JM
    Biochemistry; 1999 Jun; 38(26):8478-84. PubMed ID: 10387094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first transmembrane region of complement component-9 acts as a brake on its self-assembly.
    Spicer BA; Law RHP; Caradoc-Davies TT; Ekkel SM; Bayly-Jones C; Pang SS; Conroy PJ; Ramm G; Radjainia M; Venugopal H; Whisstock JC; Dunstone MA
    Nat Commun; 2018 Aug; 9(1):3266. PubMed ID: 30111885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of a disulfide-bonded peptide loop within human complement C9 in the species-selectivity of complement inhibitor CD59.
    Husler T; Lockert DH; Sims PJ
    Biochemistry; 1996 Mar; 35(10):3263-9. PubMed ID: 8605162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
    Podack ER; Tschoop J; Müller-Eberhard HJ
    J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sequence and topology of human complement component C9.
    Stanley KK; Kocher HP; Luzio JP; Jackson P; Tschopp J
    EMBO J; 1985 Feb; 4(2):375-82. PubMed ID: 4018030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis.
    Tschopp J; Masson D; Stanley KK
    Nature; 1986 Aug 28-Sep 3; 322(6082):831-4. PubMed ID: 2427956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and characterization of recombinant human C9 or C7 linked to single chain Fv directed to CD25.
    Raitses Gurevich M; Fishelson Z
    Mol Immunol; 2013 Oct; 55(3-4):400-8. PubMed ID: 23582305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of C5b-8 binding sites in the C9 molecule using monoclonal antibodies: participation of two separate epitopes of C9 in C5b-8 binding.
    Hatanaka M; Seya T; Yoden A; Fukamoto K; Semba T; Inai S
    Mol Immunol; 1992; 29(7-8):911-6. PubMed ID: 1378934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
    Milis L; Morris CA; Sheehan MC; Charlesworth JA; Pussell BA
    Clin Exp Immunol; 1993 Apr; 92(1):114-9. PubMed ID: 7682159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.